Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


Point of Care Diagnostics - Economic Reimbursement & Technology Trends

24 Oct 2012 - 25 Oct 2012 - London, UK



Bookmark and Share


SMi present their 9th annual Point of Care Diagnostics conference, which will bring together key members of the diagnostics and healthcare industries to discuss the implementation of technology, the reimbursements of the industry, and the connectivity of point of care technology throughout Europe and the world.

Benefits of Attending:

· Network with diagnostic manufacturers, pharmaceutical specialists and key healthcare practitioners working with POC technology

· Explore the economics, market developments, connectivity and the controversial topics of the POC industry

· Learn about the current market pulls and emerging technologies, and the ways they affect the medical diagnostics industry

· Discuss the POC industry, its potential expansion into wider markets and its future in the NHS and in European healthcare

· Consider new emerging technologies, and speak to the industry leaders at the forefront of development, manufacture and usage

Keynote Speakers include:

· Thomas Li, Senior Director, Technology Management, Roche Diagnostics, Singapore 

· Hans Winkler, Senior Director, Biomarkers, Janssen R&D (a Johnson & Johnson company) 

· David Huckle, President & Director General, ABA – France 

· Gilbert Greub, Chief of Medicine, Institute of Microbiology 

· Christopher Lowe, Director of the Institute of Biotechnology, University of Cambridge 

PLUS 2 INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS 

Tuesday 23rd of October, 2012, Copthorne Tara Hotel, London

A: Health economics, reimbursement, and market access for POC technologies

Workshop Leader: Kuo Tong, President & Founder, Quorum Consulting

8:30 – 12:30

B: The Future of Healthcare: Connecting the vision

Workshop leader: Simon Burnell, Partner, PA Consulting

13:30 – 17:30 pm

***Book before 31st May 2012 and save £300***

***Book before 29th June 2012 and save £100***

Visit our website here: http://www.smi-online.co.uk/goto/2012pointofcare8.asp

Alternatively Contact Shilan Chandi on tel: +44 (0) 20 7827 6738 or email: schandi@smi-online.co.uk



Further information
Scientific News
Combining Chemotherapy With Immune-Blocking Drug Could Stop Cancer Growing Back
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people.
Researchers Pioneer Use of Capsules to Save Materials
Wax capsule delivery systems can simplify a wide range of chemistry transformations.
Photoredox Catalyst Unlocks New Pathways for Nickel Chemistry
Using a light-activated catalyst, researchers have unlocked a new pathway in nickel chemistry to construct carbon-oxygen (C-O) bonds that would be highly valuable to pharmaceutical and agrochemical industries.
Scientists Determine How Antibiotic Gains Cancer-Killing Sulfur Atoms
In a discovery with implications for future drug design scientists have shown an unprecedented mechanism for how a natural antibiotic with antitumor properties incorporates sulfur into its molecular structure, an essential ingredient of its antitumor activity.
Familiar Drugs May Block Ebola Virus Infection
A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus’s entry into cells and halt the disease in its tracks, according to researchers at the University of Illinois at Chicago.
New Extra ‘Sticky’ Microgel Could Revolutionise Bladder Cancer Treatment
Researchers have designed a new super-efficient way of delivering an anti-cancer drug which could extend and improve the quality of life for bladder cancer patients - and perhaps save lives.
Common Class of ‘Channel Blocking’ Drugs May Find a Role in Cancer Therapy
Discoveries in fruit flies prompt unusual treatment of patient with metastatic disease.
Common Medications Could Delay Brain Injury Recovery
Drugs used to treat common complaints could delay the recovery of brain injury patients according to research by University of East Anglia (UEA) and University of Aberdeen scientists, published today in Brain Injury.
Scientists Make Strides in Therapy Preventing Addiction Relapse
Single Injection of Drug Candidate Prevents Meth Relapse in Animal Models.
New Clot-Busting Treatments Target Number One Killer
Australian researchers funded by the National Heart Foundation are a step closer to a safer and more effective way to treat heart attack and stroke via nanotechnology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!